Francesco Makovec

2.3k total citations
94 papers, 2.0k citations indexed

About

Francesco Makovec is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Francesco Makovec has authored 94 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 33 papers in Cellular and Molecular Neuroscience and 26 papers in Organic Chemistry. Recurrent topics in Francesco Makovec's work include Neuropeptides and Animal Physiology (23 papers), Receptor Mechanisms and Signaling (17 papers) and Neuroscience and Neuropharmacology Research (11 papers). Francesco Makovec is often cited by papers focused on Neuropeptides and Animal Physiology (23 papers), Receptor Mechanisms and Signaling (17 papers) and Neuroscience and Neuropharmacology Research (11 papers). Francesco Makovec collaborates with scholars based in Italy, France and United Kingdom. Francesco Makovec's co-authors include Laura Revel, Andrea Cappelli, Laura Mennuni, Maurizio Anzini, Salvatore Vomero, Renan Campos Chisté, I Setnikar, Lucio C. Rovati, Massimo Bani and Gianluca Giorgi and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

Francesco Makovec

94 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Makovec Italy 28 743 679 627 255 249 94 2.0k
Sander G. Mills United States 30 1.2k 1.6× 1.2k 1.8× 381 0.6× 257 1.0× 123 0.5× 77 2.6k
Michael P. Hedrick United States 23 689 0.9× 1.3k 1.8× 324 0.5× 145 0.6× 540 2.2× 35 2.2k
Mark G. Bock United States 29 1.8k 2.4× 1.9k 2.8× 875 1.4× 148 0.6× 326 1.3× 109 3.8k
Michael J. Coghlan United States 27 735 1.0× 1.1k 1.5× 361 0.6× 93 0.4× 211 0.8× 57 2.3k
Tiziano Bandiera Italy 30 367 0.5× 1.1k 1.6× 278 0.4× 177 0.7× 642 2.6× 89 2.5k
Graeme Semple United States 25 386 0.5× 989 1.5× 398 0.6× 401 1.6× 175 0.7× 65 1.9k
David A. Griffith United States 22 880 1.2× 1.2k 1.8× 247 0.4× 142 0.6× 249 1.0× 52 2.5k
Andrew D. White United States 18 666 0.9× 1.1k 1.7× 260 0.4× 75 0.3× 166 0.7× 37 2.0k
J Forn United States 28 645 0.9× 1.1k 1.7× 778 1.2× 98 0.4× 197 0.8× 98 2.7k
John Bondo Hansen Denmark 26 407 0.5× 1.0k 1.5× 333 0.5× 366 1.4× 183 0.7× 76 1.9k

Countries citing papers authored by Francesco Makovec

Since Specialization
Citations

This map shows the geographic impact of Francesco Makovec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Makovec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Makovec more than expected).

Fields of papers citing papers by Francesco Makovec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Makovec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Makovec. The network helps show where Francesco Makovec may publish in the future.

Co-authorship network of co-authors of Francesco Makovec

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Makovec. A scholar is included among the top collaborators of Francesco Makovec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Makovec. Francesco Makovec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paolino, Marco, Germano Giuliani, Alessandro Donati, et al.. (2018). Poly-histidine grafting leading to fishbone-like architectures. RSC Advances. 8(16). 8638–8656. 12 indexed citations
2.
Biava, Mariangela, Giovanna Poce, Claudio Battilocchio, et al.. (2011). Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents. Current Medicinal Chemistry. 18(10). 1540–1554. 10 indexed citations
3.
Lassiani, Lucia, Federico Berti, G. STEFANCICH, et al.. (2011). New Anthranilic Acid Based Antagonists with High Affinity and Selectivity for the Human Cholecystokinin Receptor 1 (hCCK1-R). Journal of Medicinal Chemistry. 54(16). 5769–5785. 4 indexed citations
4.
Cappelli, Andrea, Salvatore Valenti, Germano Giuliani, et al.. (2010). Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4‐c]quinolin‐1‐one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors. ChemMedChem. 5(5). 739–748. 26 indexed citations
5.
Rizzo, Milena, et al.. (2008). Pharmacokinetic study of a new angiotensin-AT1 antagonist by HPLC. Journal of Pharmaceutical and Biomedical Analysis. 48(2). 422–427. 2 indexed citations
6.
Tafani, Marco, Luana Schito, Tahira Anwar, et al.. (2008). Induction of autophagic cell death by a novel molecule Is increased by hypoxia. Autophagy. 4(8). 1042–1053. 29 indexed citations
7.
Cappelli, Andrea, Germano Giuliani, Andrea Gallelli, et al.. (2005). Structure–affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5HT3 receptor. Bioorganic & Medicinal Chemistry. 13(10). 3455–3460. 21 indexed citations
8.
Losi, Gabriele, et al.. (2005). Functional in vitro characterization of CR 3394: A novel voltage dependent N-methyl-d-aspartate (NMDA) receptor antagonist. Neuropharmacology. 50(3). 277–285. 12 indexed citations
9.
Rizzo, Milena, Domenica Ventrice, Susanne Procopio, et al.. (2004). Sensitive SPE–HPLC method to determine a novel angiotensin-AT1 antagonist in biological samples. Journal of Pharmaceutical and Biomedical Analysis. 35(2). 321–329. 7 indexed citations
10.
Webber, Colin E., Clare Stokes, Stefano Persiani, et al.. (2004). Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog. European Journal of Drug Metabolism and Pharmacokinetics. 29(1). 15–23. 1 indexed citations
11.
Lassiani, Lucia, et al.. (2003). Anthranilic acid derivatives: a new class of non-peptide CCK1 receptor antagonists. Bioorganic & Medicinal Chemistry. 11(5). 741–751. 19 indexed citations
12.
Lanza, Marco & Francesco Makovec. (2000). Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCKB receptors located on glutamatergic interneurons. Naunyn-Schmiedeberg s Archives of Pharmacology. 361(1). 33–38. 16 indexed citations
13.
Makovec, Francesco, Laura Revel, Ornella Letari, Laura Mennuni, & M Impicciatore. (1999). Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCKB receptor antagonist. European Journal of Pharmacology. 369(1). 81–90. 26 indexed citations
14.
Revel, Laura, Francesco Makovec, & J. Castañer. (1999). Dexloxiglumide. Drugs of the Future. 24(7). 725–725. 8 indexed citations
15.
Makovec, Francesco, et al.. (1993). Biological properties of (R)-4-benzamido-5-oxopentanoic basic derivatives as CCK-antagonists. Bioorganic & Medicinal Chemistry Letters. 3(5). 861–866. 4 indexed citations
16.
Makovec, Francesco, et al.. (1992). Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives. Journal of Medicinal Chemistry. 35(1). 28–38. 45 indexed citations
17.
Setnikar, I, et al.. (1989). Pharmacological characterisation of the smooth muscle antispasmodic agent tiropramide.. PubMed. 39(9). 1114–9. 4 indexed citations
18.
Setnikar, I, et al.. (1989). Antispasmodic activity of tiropramide.. PubMed. 39(9). 1109–14. 3 indexed citations
19.
Setnikar, I, et al.. (1987). Plasma levels of proglumetacin and its metabolites after intravenous or oral administration in the dog.. PubMed. 37(6). 698–702. 1 indexed citations
20.
Chisté, Renan Campos, et al.. (1986). Pharmacokinetics of tiropramide after single doses in man.. PubMed. 36(4). 738–44. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sander G. Mills Breakdown of academic impact, for papers by Michael P. Hedrick Breakdown of academic impact, for papers by Mark G. Bock Breakdown of academic impact, for papers by Michael J. Coghlan Breakdown of academic impact, for papers by Tiziano Bandiera Breakdown of academic impact, for papers by Graeme Semple Breakdown of academic impact, for papers by David A. Griffith Breakdown of academic impact, for papers by Andrew D. White Breakdown of academic impact, for papers by J Forn Breakdown of academic impact, for papers by John Bondo Hansen
Rankless by CCL
2026